Chemical compounds 251

Details for Australian Patent Application No. 2009265362 (hide)

Owner AstraZeneca AB

Inventors Dowling, James Edward; Read, Jon; Zheng, Xiaolan; Su, Qibin; Lamb, Michelle; Dakin, Leslie

Agent Davies Collison Cave

Pub. Number AU-B-2009265362

PCT Pub. Number WO2010/001169

Priority 61/183,278 02.06.09 US; 61/077,639 02.07.08 US

Filing date 2 July 2009

Wipo publication date 7 January 2010

Acceptance publication date 19 July 2012

International Classifications

C07D 277/34 Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

A61K 31/426 - 1,3-Thiazoles

A61K 31/427 - not condensed and containing further heterocyclic rings

A61P 35/00 Antineoplastic agents

Event Publications

27 January 2011 PCT application entered the National Phase

  PCT publication WO2010/001169 Priority application(s): WO2010/001169

19 July 2012 Application Accepted

  Published as AU-B-2009265362

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009265367-Process for the carbonylation of ethylenically unsaturated compounds, novel carbonylation ligands and catalyst systems incorporating such ligands

2009265360-Preparation of 3-pyrrole substituted 2-indolinone derivatives